Dutch agency suspends marketing of all escitalopram-containing generics
This article was originally published in SRA
The Dutch Medicines Evaluation Board has suspended the marketing authorisation of several drugs containing the generic version of Lundbeck’s antidepressant drug, Lexapro (escitalopram). The suspension will remain in place until April 2010 at the latest1.
You may also be interested in...
The European Medicines Agency is developing a strategy to ensure that women have sufficient information to make informed choices about taking medicines during pregnancy and breastfeeding.
A first-of-its-kind collaborative study has found that real-world and natural history data are comparable to placebo data from clinical trials in Duchenne muscular dystrophy.
An EU group has listed several ambitious projects to help EU regulators realize their cherished vision of using big data capabilities to support innovation and public health. But these proposals may take a backseat as COVID-19-related challenges continue.